Mouse Map2k4 (Dual Specificity Mitogen-Activated Protein Kinase Kinase 4) - Recombinant Protein
Beta LifeScience
SKU/CAT #: BLT-05161P

SDS-PAGE analysis of Mouse Map2k4 (Dual Specificity Mitogen-Activated Protein Kinase Kinase 4) - Recombinant Protein, CAT# BLT-05161P, showing >90% purity under 15% SDS-PAGE (Reduced)
Mouse Map2k4 (Dual Specificity Mitogen-Activated Protein Kinase Kinase 4) - Recombinant Protein
Beta LifeScience
SKU/CAT #: BLT-05161P
Regular price
$59500
$595.00
Sale price$44500
$445.00Save $150
/
Quantity Pricing
Pack Size | Price (USD) |
---|---|
500 µg | $1,030 (Fall Promotion) |
1 mg | $1,870 (Fall Promotion) |
For direct online orders, quantity pricing will be displayed in cart when you add 5x100ug or 10x100ug
Submit an inquiry or email inquiry@betalifesci.com for a customization request or bulk order quote.
Connect with us via the live chat in the bottom corner to receive immediate assistance.
Product Overview
Product Name | Recombinant Mouse MKK4 / MEK4 / MAP2K4 Protein |
Product Overview | This recombinant mouse MKK4 / MEK4 / MAP2K4 protein includes amino acids 2-397aa of the target gene is expressed in Baculovirus-Insect Cells.The protein is supplied in lyophilized form and formulated in phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5% trehaloseprior to lyophilization. |
Target Uniprot Id | P47809 |
Recommended Name | Dual specificity mitogen-activated protein kinase kinase 4 |
Gene Name | Map2k4 |
Synonyms | JNKK1;MEK4;MKK4;PRKMK4;Sek1;Serk1 |
Species | Mouse |
Predicted Molecular Mass | 72 kDa |
Expression System | Insect Cell |
Expression Range | 2-397aa |
Tag | N-His-GST |
Purity | >90% |
Formulation | Lyophilized |
Buffer | Phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5%Trehalose |
Storage Condition | 1. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. 2. Avoid repeated freeze-thaw cycles. 3. Store working aliquots at 4°C for up to one week. 4. In general, protein in liquid form is stable for up to 6 months at -20°C/-80°C. Protein in lyophilized powder form is stable for up to 12 months at -20°C/-80°C. |
Reconstitution Instruction | Briefly centrifuged the vial prior to opening to bring the contents to the bottom. Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. It is recommended to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default final concentration of glycerol is 50%. |
Applications | Positive Control; Immunogen; SDS-PAGE; WB |
Research Area | Others |
Target Function | Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K7/MKK7, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The phosphorylation of the Thr residue by MAP2K7/MKK7 seems to be the prerequisite for JNK activation at least in response to proinflammatory cytokines, while other stimuli activate both MAP2K4/MKK4 and MAP2K7/MKK7 which synergistically phosphorylate JNKs. MAP2K4 is required for maintaining peripheral lymphoid homeostasis. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Whereas MAP2K7/MKK7 exclusively activates JNKs, MAP2K4/MKK4 additionally activates the p38 MAPKs MAPK11, MAPK12, MAPK13 and MAPK14. |
Subcellular Location | Cytoplasm. Nucleus. |
Protein Family | Protein kinase superfamily, STE Ser/Thr protein kinase family, MAP kinase kinase subfamily |
Tissue Specificity | Strong expression is detected in most of the central nervous system and in liver and thymus during early stages of development. While expression in nervous system increases over time, expression in fetal liver and thymus gradually decreases as embryogenes |